This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Direct control of CAR T cells through small molecule-regulated antibodies
Nature Communications Open Access 29 January 2021
-
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Biomarker Research Open Access 22 January 2018
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DeFrancesco, L. CAR-T's forge ahead, despite Juno deaths. Nat Biotechnol 35, 6–7 (2017). https://doi.org/10.1038/nbt0117-6b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0117-6b
This article is cited by
-
Direct control of CAR T cells through small molecule-regulated antibodies
Nature Communications (2021)
-
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Biomarker Research (2018)
-
Human antibody-based chemically induced dimerizers for cell therapeutic applications
Nature Chemical Biology (2018)
-
Designing natural and synthetic immune tissues
Nature Materials (2018)
-
Adverse Effects Associated with Clinical Applications of CAR Engineered T Cells
Archivum Immunologiae et Therapiae Experimentalis (2018)